# GluMetrics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glumetrics

- Industry: Medical Devices & Equipment
- Headquarters: Irvine, US
- Website: www.glumetrics.com
- Total disclosed funding: $44M
- Latest round: Series D (May 7, 2012)
- Investors on record: 5

## About

GluMetrics is a healthcare technology company dedicated to enhancing diabetes management through innovative glucose monitoring solutions, aimed at improving patient outcomes and quality of life.Founded in 2005 in Irvine, US, GluMetrics specializes in developing advanced glucose monitoring systems. The company does not have known subsidiaries or a parent company. It has successfully completed a total of 12 deals, with the most recent deal on January 30, 2014, when GluMetrics raised USD 0.35 mn in a VENTURE DEBT funding round, contributing to a total of USD 4.00 mn raised.GluMetrics specializes in providing advanced glucose monitoring solutions designed to improve diabetes management. Their primary offerings include state-of-the-art continuous glucose monitoring systems, which enable users to track their glucose levels in real-time, facilitating better health decisions. These products cater to individuals with diabetes, healthcare professionals, and institutions looking to enhance diabetes care, and are distributed across markets in North America, Europe, and Asia.The company generates revenue through direct sales of its glucose monitoring systems and related software solutions via their e-commerce platform, and partnerships with healthcare providers and hospitals. This multi-channel strategy allows for broad market access and supports user convenience. Pricing for their flagship monitoring devices is strategically positioned to attract both individual users and healthcare facilities. Revenue is further supported through service subscriptions, ensuring regular income and fostering customer loyalty.GluMetrics plans to introduce new glucose monitoring products aimed at enhancing user experience and expanding functionality within the next year. The company is targeting geographical expansion into key markets in Europe and Asia by the end of 2025. The recent funding raised in January 2014 will be utilized to support these product development and market entry initiatives, helping the company achieve its growth objectives.

## Funding rounds

- Series D, May 7, 2012, $1.8M — Advanced Technology Ventures
- Series D, Mar 7, 2012, $13M — Advanced Technology Ventures, Versant Ventures, New Leaf Venture Partners, Kaiser Permanente Ventures
- Series C, Jul 15, 2008, $20M — Advanced Technology Ventures, Sprout Group, Versant Ventures, Kaiser Permanente Ventures
- Series B, Jul 10, 2006, $9M — Advanced Technology Ventures, Versant Ventures

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series B, Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series C, Series D
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series C
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series C, Series D
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series D